A radiopharmaceuticals schedule for imaging in paediatrics-Reference-Cited by-同舟云学术

A radiopharmaceuticals schedule for imaging in paediatrics

Published:1990 Issue:3-4 Volume:17 Page:127-129
ISSN:0340-6997
Container-title:European Journal of Nuclear Medicine
language:en
Short-container-title:Eur J Nucl Med

Author:

,Piepsz A.,Hahn K.,Roca I.,Ciofetta G.,Toth G.,Gordon I.,Kolinska J.,Gwidlet J.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00811439.pdf

Reference9 articles.

1. Bell EG, McAfee JG, Subramanian G (1974) Radiopharmaceuticals in Pediatrics. In: James AE, Wagner HN, Cooke RE (eds) Pediatric nuclear medicine. Saunderns, London pp 84?94

2. Dolphin GW (1968) The risk of thyroid cancer following radiation. Health Phys 15:219?228

3. ICRP 52 (1987) Protection of the patient in nuclear medicine. Ann ICRF 17

4. ICRP 53 (1987) Radiation dose to the patient from radiopharmaceuticals. Ann ICRP 18

5. International Commission on Radiological Protection (1965) Protection Recommendations. ICRP Publication 9 September 1965

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EANM procedural recommendations for managing the paediatric patient in diagnostic nuclear medicine;European Journal of Nuclear Medicine and Molecular Imaging;2023-08-09

2. Responsivity of the Striatal Dopamine System to Methylphenidate—A Within-Subject I-123-β-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder;Frontiers in Psychiatry;2022-04-14

3. Optimization of pediatric FDG-PET/CT examinations based on physical indicators using the SiPM-PET/CT system;Nuclear Medicine Communications;2022-01-17

4. Radiation Dose to Pediatric Patients From Radiopharmaceuticals;Seminars in Nuclear Medicine;2021-12

5. Responsivity of the striatal dopamine system to methylphenidate – a within-subject I-123-ß-CIT-SPECT study in children and adolescents with Attention-Deficit/Hyperactivity Disorder;2021-11-23